{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:24:16Z","timestamp":1793316256917,"version":"4.5.0"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To update the 2000 American Academy of Neurology (AAN) practice parameter on anticonvulsant prophylaxis in patients with newly diagnosed brain tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following the 2017 AAN methodologies, a systematic literature review utilizing PubMed, EMBASE Library, Cochrane, and Web of Science databases was performed. The studies were rated based on the AAN therapeutic or causation classification of evidence (class I-IV).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-seven articles were selected for final analysis. There were limited high-level, class I studies and mostly class II and III studies. The AAN affirmed the value of these guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recommendations<\/jats:title>\n                    <jats:p>In patients with newly diagnosed brain tumors who have not had a seizure, clinicians should not prescribe antiepileptic drugs (AEDs) to reduce the risk of seizures (level A). In brain tumor patients undergoing surgery, there is insufficient evidence to recommend prescribing AEDs to reduce the risk of seizures in the peri- or postoperative period (level C). There is insufficient evidence to support prescribing valproic acid or levetiracetam with the intent to prolong progression-free or overall survival (level C). Physicians may consider the use of levetiracetam over older AEDs to reduce side effects (level C). There is insufficient evidence to support using tumor location, histology, grade, molecular\/imaging features when deciding whether or not to prescribe prophylactic AEDs (level U).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noab152","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:10:33Z","timestamp":1624518633000},"page":"1835-1844","source":"Crossref","is-referenced-by-count":160,"title":["SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors"],"prefix":"10.1093","volume":"23","author":[{"given":"Tobias","family":"Walbert","sequence":"first","affiliation":[{"name":"Department of Neurology and Neurosurgery, Henry Ford Health System and Wayne State University, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A","family":"Harrison","sequence":"additional","affiliation":[{"name":"Department of Neuro-oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schiff","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Virginia Health System, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward K","family":"Avila","sequence":"additional","affiliation":[{"name":"Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merry","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neuro-oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmaja","family":"Kandula","sequence":"additional","affiliation":[{"name":"Division of Clinical Neurophysiology and Epilepsy, New York Presbyterian Hospital-Weill Cornell Medicine, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5283-7476","authenticated-orcid":false,"given":"Jong Woo","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brigham and Women\u2019s Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Le Rhun","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurosurgery, Brain Tumor Center & Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen H J","family":"Stevens","sequence":"additional","affiliation":[{"name":"Rose Ella Burkhardt Brain Tumor and Neuro-oncology Center, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Vogelbaum","sequence":"additional","affiliation":[{"name":"Department of NeuroOncology, Moffitt Cancer Center, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Wick","sequence":"additional","affiliation":[{"name":"Neurology Clinic and Neurooncology Program, Heidelberg University and German Cancer Research Center, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1748-174X","authenticated-orcid":false,"given":"Michael","family":"Weller","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick Y","family":"Wen","sequence":"additional","affiliation":[{"name":"Center For Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R","family":"Gerstner","sequence":"additional","affiliation":[{"name":"Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA"},{"name":"Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,26]]},"reference":[{"issue":"5","key":"2021110300452330900_CIT0001","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/era.10.48","article-title":"Seizures in low- and high-grade gliomas: current management and future outlook","volume":"10","author":"Vecht","year":"2010","journal-title":"Expert Rev Anticancer Ther."},{"key":"2021110300452330900_CIT0002","doi-asserted-by":"crossref","first-page":"iv55","DOI":"10.1093\/neuonc\/nos199","article-title":"Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments","volume":"14","author":"Rud\u00e0","year":"2012","journal-title":"Neuro Oncol."},{"issue":"6","key":"2021110300452330900_CIT0003","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/WCO.0b013e32833e996c","article-title":"Epilepsy in brain tumor patients","volume":"23","author":"Rossetti","year":"2010","journal-title":"Curr Opin Neurol."},{"issue":"3","key":"2021110300452330900_CIT0004","first-page":"134","article-title":"Epilepsy in the end of life phase of brain tumor patients: a systematic review","volume":"1","author":"Koekkoek","year":"2014","journal-title":"Neurooncol Pract."},{"issue":"2","key":"2021110300452330900_CIT0005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11060-014-1449-7","article-title":"Weight of epilepsy in brain tumor patients","volume":"118","author":"Maschio","year":"2014","journal-title":"J Neurooncol."},{"issue":"5","key":"2021110300452330900_CIT0006","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","article-title":"Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management","volume":"6","author":"van Breemen","year":"2007","journal-title":"Lancet Neurol."},{"issue":"7","key":"2021110300452330900_CIT0007","first-page":"941","article-title":"Management of brain metastases","volume":"13","author":"Wen","year":"1999","journal-title":"Oncology (Williston Park)."},{"issue":"2","key":"2021110300452330900_CIT0008","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11940-020-0613-y","article-title":"Epilepsy in brain metastasis: an emerging entity","volume":"22","author":"Rud\u00e0","year":"2020","journal-title":"Curr Treat Options Neurol."},{"issue":"10","key":"2021110300452330900_CIT0009","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","article-title":"Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"54","author":"Glantz","year":"2000","journal-title":"Neurology."},{"issue":"1-2","key":"2021110300452330900_CIT0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01420191","article-title":"Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumours","volume":"103","author":"Franceschetti","year":"1990","journal-title":"Acta Neurochir (Wien)."},{"issue":"4","key":"2021110300452330900_CIT0011","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1212\/WNL.46.4.985","article-title":"A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors","volume":"46","author":"Glantz","year":"1996","journal-title":"Neurology."},{"issue":"5","key":"2021110300452330900_CIT0012","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3171\/jns.1983.58.5.0672","article-title":"Phenytoin and postoperative epilepsy. A double-blind study","volume":"58","author":"North","year":"1983","journal-title":"J Neurosurg."},{"issue":"3","key":"2021110300452330900_CIT0013","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1227\/00006123-198503000-00002","article-title":"Postoperative prophylactic anticonvulsant therapy in cerebral gliomas","volume":"16","author":"Boarini","year":"1985","journal-title":"Neurosurgery."},{"issue":"4","key":"2021110300452330900_CIT0014","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00165714","article-title":"Brain metastasis from melanoma","volume":"1","author":"Byrne","year":"1983","journal-title":"J Neurooncol."},{"issue":"10","key":"2021110300452330900_CIT0015","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1200\/JCO.1988.6.10.1621","article-title":"Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis","volume":"6","author":"Cohen","year":"1988","journal-title":"J Clin Oncol."},{"issue":"1","key":"2021110300452330900_CIT0016","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1212\/WNL.40.1.158","article-title":"The role of radiation therapy following resection of single brain metastasis from melanoma","volume":"40","author":"Hagen","year":"1990","journal-title":"Neurology."},{"issue":"6","key":"2021110300452330900_CIT0017","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0090-3019(81)90227-5","article-title":"The role of anticonvulsant medications in the management of patients with anaplastic gliomas","volume":"16","author":"Mahaley","year":"1981","journal-title":"Surg Neurol."},{"issue":"7","key":"2021110300452330900_CIT0018","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/archneur.1995.00540310091021","article-title":"The course of seizure disorders in patients with malignant gliomas","volume":"52","author":"Moots","year":"1995","journal-title":"Arch Neurol."},{"key":"2021110300452330900_CIT0019","volume-title":"Clinical Practice Guideline Process Manual","author":"Gronseth","year":"2017","edition":"2017"},{"issue":"2","key":"2021110300452330900_CIT0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1017\/S0317167100053361","article-title":"Prophylactic anticonvulsants in patients with brain tumour","volume":"30","author":"Forsyth","year":"2003","journal-title":"Can J Neurol Sci."},{"issue":"1","key":"2021110300452330900_CIT0021","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11060-012-0802-y","article-title":"Seizure prophylaxis and melanoma brain metastases","volume":"108","author":"Goldlust","year":"2012","journal-title":"J Neurooncol."},{"key":"2021110300452330900_CIT0022","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.wneu.2016.10.062","article-title":"Risk factors of preoperative and early postoperative seizures in patients with Meningioma: a retrospective single-center cohort study","volume":"97","author":"Skardelly","year":"2017","journal-title":"World Neurosurg."},{"issue":"2","key":"2021110300452330900_CIT0023","doi-asserted-by":"crossref","first-page":"107","DOI":"10.17712\/nsj.2017.2.20160570","article-title":"Incidence, risk factors and outcomes of seizures occurring after craniotomy for primary brain tumor resection","volume":"22","author":"Al-Dorzi","year":"2017","journal-title":"Neurosciences (Riyadh)."},{"issue":"1","key":"2021110300452330900_CIT0024","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11060-014-1402-9","article-title":"Efficacy of postoperative seizure prophylaxis in intra-axial brain tumor resections","volume":"118","author":"Ansari","year":"2014","journal-title":"J Neurooncol."},{"issue":"2","key":"2021110300452330900_CIT0025","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3171\/2009.2.JNS081132","article-title":"Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. Clinical article","volume":"111","author":"Chaichana","year":"2009","journal-title":"J Neurosurg."},{"issue":"2","key":"2021110300452330900_CIT0026","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11060-014-1564-5","article-title":"Antiepileptic drug prophylaxis in primary brain tumor patients: is current practice in agreement to the consensus?","volume":"120","author":"de Oliveira","year":"2014","journal-title":"J Neurooncol."},{"issue":"2","key":"2021110300452330900_CIT0027","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/0028-3886.111118","article-title":"A retrospective two-center study of antiepileptic prophylaxis in patients with surgically treated high-grade gliomas","volume":"61","author":"Garbossa","year":"2013","journal-title":"Neurol India."},{"issue":"4","key":"2021110300452330900_CIT0028","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/1793-5482.125658","article-title":"Levetiracetam seizure prophylaxis in craniotomy patients at high risk for postoperative seizures","volume":"8","author":"Gokhale","year":"2013","journal-title":"Asian J Neurosurg."},{"issue":"4","key":"2021110300452330900_CIT0029","first-page":"192","article-title":"Prophylactic anticonvulsants for gliomas: a seven-year retrospective analysis","volume":"2","author":"Lapointe","year":"2015","journal-title":"Neurooncol Pract."},{"issue":"7","key":"2021110300452330900_CIT0030","doi-asserted-by":"crossref","first-page":"e0158206","DOI":"10.1371\/journal.pone.0158206","article-title":"Epilepsy in adults with supratentorial glioblastoma: incidence and influence factors and prophylaxis in 184 patients","volume":"11","author":"Liang","year":"2016","journal-title":"PLoS One."},{"issue":"10","key":"2021110300452330900_CIT0031","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00701-013-1826-6","article-title":"Risk of seizure and its clinical implication in the patients with cerebral metastasis from lung cancer","volume":"155","author":"Lee","year":"2013","journal-title":"Acta Neurochir (Wien)."},{"issue":"3","key":"2021110300452330900_CIT0032","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11060-009-9977-2","article-title":"Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experience","volume":"96","author":"Lwu","year":"2010","journal-title":"J Neurooncol."},{"issue":"5","key":"2021110300452330900_CIT0033","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10072-006-0708-6","article-title":"Tumour-associated epilepsy: clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group","volume":"27","author":"Riva","year":"2006","journal-title":"Neurol Sci."},{"issue":"11","key":"2021110300452330900_CIT0034","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.clineuro.2013.08.023","article-title":"Considerations in prophylaxis for tumor-associated epilepsy: prevention of status epilepticus and tolerability of newer generation AEDs","volume":"115","author":"Wychowski","year":"2013","journal-title":"Clin Neurol Neurosurg."},{"issue":"4","key":"2021110300452330900_CIT0035","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3171\/2012.12.JNS111970","article-title":"A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors","volume":"118","author":"Wu","year":"2013","journal-title":"J Neurosurg."},{"key":"2021110300452330900_CIT0036","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.wneu.2016.10.079","article-title":"Prophylactic antiepileptic drug use in patients with brain tumors undergoing craniotomy","volume":"98","author":"Lockney","year":"2017","journal-title":"World Neurosurg."},{"issue":"3","key":"2021110300452330900_CIT0037","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3171\/2010.5.JNS091972","article-title":"Postoperative seizures following the resection of convexity meningiomas: are prophylactic anticonvulsants indicated? Clinical article","volume":"114","author":"Sughrue","year":"2011","journal-title":"J Neurosurg."},{"issue":"1","key":"2021110300452330900_CIT0038","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11060-010-0235-4","article-title":"Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery","volume":"101","author":"Zachenhofer","year":"2011","journal-title":"J Neurooncol."},{"issue":"7","key":"2021110300452330900_CIT0039","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1200\/JCO.2015.63.6563","article-title":"Does valproic acid or levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma","volume":"34","author":"Happold","year":"2016","journal-title":"J Clin Oncol."},{"issue":"7","key":"2021110300452330900_CIT0040","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/neuonc\/not057","article-title":"Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme","volume":"15","author":"Kerkhof","year":"2013","journal-title":"Neuro Oncol."},{"issue":"17","key":"2021110300452330900_CIT0041","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/cncr.29439","article-title":"Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme","volume":"121","author":"Kim","year":"2015","journal-title":"Cancer."},{"issue":"3","key":"2021110300452330900_CIT0042","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11060-016-2054-8","article-title":"Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II\/III gliomas treated with temozolomide","volume":"127","author":"Redjal","year":"2016","journal-title":"J Neurooncol."},{"issue":"3","key":"2021110300452330900_CIT0043","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/02688697.2011.638996","article-title":"Effect of valproic acid on the outcome of glioblastoma multiforme","volume":"26","author":"Tsai","year":"2012","journal-title":"Br J Neurosurg."},{"issue":"12","key":"2021110300452330900_CIT0044","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","article-title":"Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for glioblastoma","volume":"77","author":"Weller","year":"2011","journal-title":"Neurology."},{"issue":"10","key":"2021110300452330900_CIT0045","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/jnnp-2014-308584","article-title":"Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study","volume":"86","author":"Iuchi","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"1","key":"2021110300452330900_CIT0046","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jocn.2014.05.036","article-title":"Epilepsy in patients with gliomas: incidence and control of seizures","volume":"22","author":"Iuchi","year":"2015","journal-title":"J Clin Neurosci."},{"issue":"9","key":"2021110300452330900_CIT0047","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40263-013-0094-6","article-title":"Levetiracetam compared with valproic acid for the prevention of postoperative seizures after supratentorial tumor surgery: a retrospective chart review","volume":"27","author":"Lee","year":"2013","journal-title":"CNS Drugs."},{"issue":"6","key":"2021110300452330900_CIT0048","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3171\/2010.5.JNS091367","article-title":"Seizures in patients with glioma treated with phenytoin and levetiracetam","volume":"113","author":"Merrell","year":"2010","journal-title":"J Neurosurg."},{"issue":"9","key":"2021110300452330900_CIT0049","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/01.wnl.0000324624.52935.46","article-title":"Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery","volume":"71","author":"Milligan","year":"2008","journal-title":"Neurology."},{"issue":"2","key":"2021110300452330900_CIT0050","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/ene.13518","article-title":"Seizure-susceptible brain regions in glioblastoma: identification of patients at risk","volume":"25","author":"Cayuela","year":"2018","journal-title":"Eur J Neurol."},{"issue":"3","key":"2021110300452330900_CIT0051","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11060-011-0779-y","article-title":"Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomas","volume":"107","author":"Das","year":"2012","journal-title":"J Neurooncol."},{"issue":"3","key":"2021110300452330900_CIT0052","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/archneurol.2010.2","article-title":"Morphological characteristics of brain tumors causing seizures","volume":"67","author":"Lee","year":"2010","journal-title":"Arch Neurol."},{"issue":"6","key":"2021110300452330900_CIT0053","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3171\/2017.2.JNS162315","article-title":"New-onset seizure during and after brain tumor excision: a risk assessment analysis","volume":"128","author":"Oushy","year":"2018","journal-title":"J Neurosurg."},{"issue":"6","key":"2021110300452330900_CIT0054","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/ana.24522","article-title":"Predictors of preoperative and early postoperative seizures in patients with intra-axial primary and metastatic brain tumors: a retrospective observational single center study","volume":"78","author":"Skardelly","year":"2015","journal-title":"Ann Neurol."},{"issue":"7","key":"2021110300452330900_CIT0055","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/neuonc\/nov303","article-title":"Predicting outcome of epilepsy after meningioma resection","volume":"18","author":"Wirsching","year":"2016","journal-title":"Neuro Oncol."},{"issue":"10","key":"2021110300452330900_CIT0056","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med."},{"key":"2021110300452330900_CIT0057","first-page":"1","article-title":"Effectiveness of perioperative antiepileptic drug prophylaxis for early and late seizures following oncologic neurosurgery: a meta-analysis","author":"Joiner","year":"2018","journal-title":"J Neurosurg."},{"key":"2021110300452330900_CIT0058","first-page":"CD007286","article-title":"Antiepileptic drugs as prophylaxis for postcraniotomy seizures","volume":"4","author":"Greenhalgh","year":"2020","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"2021110300452330900_CIT0059","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3747\/co.v13i6.107","article-title":"The use of prophylactic anticonvulsants in patients with brain tumours \u2013 a systematic review","volume":"13","author":"Perry","year":"2006","journal-title":"Curr Oncol."},{"issue":"12","key":"2021110300452330900_CIT0060","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.4065\/79.12.1489","article-title":"Seizure prophylaxis in patients with brain tumors: a meta-analysis","volume":"79","author":"Sirven","year":"2004","journal-title":"Mayo Clin Proc."},{"key":"2021110300452330900_CIT0061","first-page":"CD004424","article-title":"Antiepileptic drugs for preventing seizures in people with brain tumors","volume":"2","author":"Tremont-Lukats","year":"2008","journal-title":"Cochrane Database Syst Rev."},{"issue":"8","key":"2021110300452330900_CIT0062","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1212\/01.WNL.0000123693.82339.FC","article-title":"Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the therapeutics and technology assessment subcommittee and quality standards subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"62","author":"French","year":"2004","journal-title":"Neurology."},{"issue":"5","key":"2021110300452330900_CIT0063","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1528-1167.2009.02129.x","article-title":"Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia."},{"issue":"6","key":"2021110300452330900_CIT0064","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/neuonc\/nov269","article-title":"Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy","volume":"18","author":"Armstrong","year":"2016","journal-title":"Neuro Oncol."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noab152\/39812050\/noab152.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/23\/11\/1835\/41063909\/noab152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/23\/11\/1835\/41063909\/noab152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T20:46:47Z","timestamp":1635886007000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/23\/11\/1835\/6310125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,26]]},"references-count":64,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,6,26]]},"published-print":{"date-parts":[[2021,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noab152","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2021,6,26]]}}}